Sparrow Pharmaceuticals

Cardiometabolic Therapeutics · Prescription Drugs

Overview

Sparrow Pharmaceuticals is an emerging clinical-stage biopharmaceutical company developing novel, targeted therapies for disorders of corticosteroid excess.

Funding and backers

Team
51-200
employees, estimated range
Backers
3
RA Capital Management, OrbiMed
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
RA Capital Management fund OrbiMed fund USVP fund
Investors in similar startupsfunds that back the companies most like this one
Atlas Venture
backs Kailera, 2026 Akero Therapeutics, Inc.
GV
backs LifeMine
ARCH Venture Partners
backs LifeMine
Foresite Capital
backs GH Research
Nextech Invest
backs Atavistik Bio
venBio Partners
backs 2026 Akero Therapeutics, Inc.
Similar startupsby what they do, their industry and backers
PAhR TherapeuticsSeed $14M · 15 mo ago
PAhR Therapeutics is a clinical-stage biotech company advancing innovative therapies to treat pulmonary arterial hypertension (PAH) through…
Imbria
Imbria Pharmaceuticals is developing novel cardiovascular therapies targeting cardiac energy metabolism to address serious cardiovascular…
KaileraFounded 2024 · 51-200 employees · 15 roles
Kailera is a late clinical-stage biotechnology company advancing a diversified pipeline of GLP-1 therapies to provide options for people…
Verdiva BioSeries A $410M · 22 mo ago · 201-500 employees
Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related…
LifeMineVenture round $263M · 3 mo ago · Founded 2017 · 501-1000 employees · 1 role
LifeMine is a clinical-stage biopharmaceutical company pioneering a bold new approach, Top-Down Drug DiscoveryTM, which leverages…
2026 Akero Therapeutics, Inc.Venture round $45.5M · 7 yr ago · Founded 2017 · 51-200 employees · 2 roles
Akero Therapeutics is a clinical-stage company developing transformational therapies for people with metabolic dysfunction-associated…

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors3
USVPVia a fund
93 portfolio companies: Zefr, Zerto, Zero Networks and 90 more
OrbiMedVia a fund
196 portfolio companies: Cookiedatabase.org, ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD., Z-Alpha Therapeutics and 193 more
RA Capital ManagementVia a fund
222 portfolio companies: Verdiva Bio, PLEASE READ THIS AG, Vivace Therapeutics and 219 more
Report a mistake